TY - JOUR T1 - EMA suspends licence for ingenol mebutate (Picato) JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 51 LP - 51 DO - 10.1136/dtb.2020.000012 VL - 58 IS - 4 A2 - , Y1 - 2020/04/01 UR - http://dtb.bmj.com/content/58/4/51.abstract N2 - Overview of: Medicines and Healthcare products Regulatory Agency. Ingenol mebutate gel (Picatoâ–¼): suspension of the licence due to risk of skin malignancy. Drug Safety Update 2020;13(7):1. ER -